Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Hospital Care Partnering Directory 2018: Deals Between the World's Leading Pharmaceutical and Biotechnology Companies Since 2012

Research and Markets
Posted on: 20 Mar 18
Global Hospital Care Partnering Directory 2018: Deals Between the World's Leading Pharmaceutical and Biotechnology Companies Since 2012

PR Newswire

DUBLIN, March 20, 2018

DUBLIN, March 20, 2018 /PRNewswire/ --

The "Global Hospital Care Partnering 2012-2018: Deal trends, players and financials" report has been added to's offering.

Global Hospital Care Partnering 2012 to 2018 provides the full collection of Hospital Care disease deals signed between the world's pharmaceutical and biotechnology companies since 2012.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Hospital Care disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Hospital Care deals.

The report presents financial deal terms values for Hospital Care deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

In addition, a comprehensive appendix is provided with each report of all Hospital Care partnering deals signed and announced since 2012. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Report scope

Global Hospital Care Partnering 2012 to 2018 includes:

  • Trends in Hospital Care dealmaking in the biopharma industry since 2012
  • Analysis of Hospital Care deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to hundreds of Hospital Care deal contract documents
  • Comprehensive access to over 3500 Hospital Care deal records
  • The leading Hospital Care deals by value since 2012
  • Most active Hospital Care dealmakers since 2012

Available deals and contracts are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Stage of development at signing
  • Deal component type
  • Technology type
  • Specific therapy indication

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Hospital Care dealmaking

2.1. Introduction
2.2. Hospital Care partnering over the years
2.3. Hospital Care partnering by deal type
2.4. Hospital Care partnering by industry sector
2.5. Hospital Care partnering by stage of development
2.6. Hospital Care partnering by technology type
2.7. Hospital Care partnering by therapeutic indication

Chapter 3 - Financial deal terms for Hospital Care partnering

3.1. Introduction
3.2. Disclosed financials terms for Hospital Care partnering
3.3. Hospital Care partnering headline values
3.4. Hospital Care deal upfront payments
3.5. Hospital Care deal milestone payments
3.6. Hospital Care royalty rates

Chapter 4 - Leading Hospital Care deals and dealmakers

4.1. Introduction
4.2. Most active in Hospital Care partnering
4.3. List of most active dealmakers in Hospital Care
4.4. Top Hospital Care deals by value

Chapter 5 - Hospital Care contract document directory

5.1. Introduction
5.2. Hospital Care partnering deals where contract document available

Chapter 6 - Hospital Care dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by Hospital Care therapeutic target

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets

PR Newswire

Last updated on: 20/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.